Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-04457845 with integrated exposure-based therapy for women with PTSD and alcohol dependence
2014-002456-90Phase 2Terminated
- Sponsor
- Beroendecentrum Stockholm
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in post-traumatic stress disorder (PTSD) and alcohol dependence comparing PF-04457845 plus integrated exposure-based therapy with Placebo plus integrated exposure-based therapy (2 arms). Primary endpoint: CAPS-DX PTSD symptom severity. Started Sep 2014; status: terminated.
02
Drugs
JZP-150
03
Conditions
post-traumatic stress disorder (PTSD)alcohol dependence
Beyond the preview
Go deeper on 2014-002456-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002456-90.